DR. CARMELO A MILANO, M.D.
Radiology at 27 St, Lumberton, NC
License number
North Carolina 00-35171
Category
Radiology
Type
Thoracic Surgery (Cardiothoracic Vascular Surgery)
Address
Address
2
403 W 27Th St, Lumberton, NC 28358
4101 N Roxboro St, Durham, NC 27704
4101 N Roxboro St, Durham, NC 27704
Phone
(919) 684-8111
Organization information
See more information about CARMELO A MILANO at bizstanding.comCarmelo Milano MD
2936 N Elm St, Lumberton, NC 28358
Industry:
Thoracic Surgery, Surgeons, Internist, ...
Phone:
(910) 617-6619 (Phone)
Carmelo Asessio Milano
Carmelo Milano MD
403 W 27 St, Lumberton, NC 28358
Categories:
Physicians & Surgeons
Phone:
(919) 684-8111 (Phone)
Professional information
Dr. Carmelo A Milano, Durham NC - MD (Doctor of Medicine)
Specialties:
Cardiac Surgery
Address:
Duke University Medical Center THS
200 Trent Dr, Durham 27710
(919) 681-4760 (Phone)
200 Trent Dr, Durham 27710
(919) 681-4760 (Phone)
Procedures:
Coronary Angioplasty, Atherectomy and Stent
Conditions:
Congestive Heart Failure, Heart Attack (Acute Myocardial Infarction)
Certifications:
General Surgery, 2007, Thoracic Cardiovascular Surgery, 2000
Languages:
English
Hospitals:
Duke University Medical Center THS
200 Trent Dr, Durham 27710
Duke University Hospital
2301 Erwin Rd, Durham 27710
Durham Regional Hospital
3643 North Roxboro Rd, Durham 27704
Southeastern Regional Medical Center
300 West 27Th St, Lumberton 28358
200 Trent Dr, Durham 27710
Duke University Hospital
2301 Erwin Rd, Durham 27710
Durham Regional Hospital
3643 North Roxboro Rd, Durham 27704
Southeastern Regional Medical Center
300 West 27Th St, Lumberton 28358
Education:
Medical School
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1990
Duke University Med Center
Graduated: 1992
Duke University Mc
Graduated: 1993
Graduated: 1999
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1990
Duke University Med Center
Graduated: 1992
Duke University Mc
Graduated: 1993
Graduated: 1999
Background:
Malpractice Claim: 1 time(s)
Carmelo A Milano, Durham NC
Specialties:
Vascular Surgeon
Address:
4101 N Roxboro St, Durham, NC 27704
Board certifications:
American Board of Surgery Certification in Surgery, American Board of Thoracic Surgery Certification in Thoracic and Cardiac Surgery (Thoracic Surgery)
Carmelo Milano, Lumberton NC
Specialties:
Surgery, Vascular Surgery, Thoracic Surgery, Cardiothoracic Vascular Surgery, Cardiovascular Disease
Work:
Duke Cardiovascular Surgery of Lumberton
2936 N Elm St, Lumberton, NC 28358 Durham Va Medical Center
508 Fulton St, Durham, NC 27705 Private Diagnostic Clinic
3643 N Roxboro St, Durham, NC 27704 Private Diagnostic Clinic
40 Duke Medicine Cir, Durham, NC 27710 Private Diagnostic Clinic
20 Duke Medicine Cir, Durham, NC 27710 Private Diagnostic Clinic
30 Duke Medicine Cir, Durham, NC 27710
2936 N Elm St, Lumberton, NC 28358 Durham Va Medical Center
508 Fulton St, Durham, NC 27705 Private Diagnostic Clinic
3643 N Roxboro St, Durham, NC 27704 Private Diagnostic Clinic
40 Duke Medicine Cir, Durham, NC 27710 Private Diagnostic Clinic
20 Duke Medicine Cir, Durham, NC 27710 Private Diagnostic Clinic
30 Duke Medicine Cir, Durham, NC 27710
Education:
University of Chicago (1990)
Use Of Exogenous -Adrenergic Receptor And -Adrenergic Receptor Kinase Gene Constructs To Enhance Myocardial Function
US Patent:
6436908, Aug 20, 2002
Filed:
Apr 5, 1999
Appl. No.:
09/285677
Inventors:
Walter J. Koch - Durham NC
Robert J. Lefkowitz - Durham NC
Carmelo A. Milano - Durham NC
Howard A. Royman - Chapel Hill NC
Robert J. Lefkowitz - Durham NC
Carmelo A. Milano - Durham NC
Howard A. Royman - Chapel Hill NC
Assignee:
Duke University - Durham NC
International Classification:
A61K 3170
US Classification:
514 44, 424 932, 4353201, 435455, 435458
Abstract:
The present invention deals with gene therapy for treating chronic heart failure and other cardiac disease states which are accompanied by a reduced number or functioning of myocardial beta-adrenergic receptors (-AR). -AR receptor function is augmented in transgenic animals by delivery and expression of a beta-2-adrenergic receptor gene or a gene encoding a beta adrenergic receptor kinase inhibitor, resulting in increased in vivo left ventricular function. The present invention includes recombinant plasmid vectors, alternative beta-adrenergic receptor gene delivery strategies, and transgenic mice carrying a -AR transgene, a -ARK transgene, or a -ARK inhibitor transgene.
Use Of Exogenous Β-Adrenergic Receptor And Β-Adrenergic Receptor Kinase Gene Constructs To Enhance Myocardial Function
US Patent:
7060871, Jun 13, 2006
Filed:
Jun 28, 2002
Appl. No.:
10/183344
Inventors:
Walter J. Koch - Durham NC, US
Robert J. Lefkowitz - Durham NC, US
Carmelo A. Milano - Durham NC, US
Howard A. Rockman - Chapel Hill NC, US
Robert J. Lefkowitz - Durham NC, US
Carmelo A. Milano - Durham NC, US
Howard A. Rockman - Chapel Hill NC, US
Assignee:
Duke University - Durham NC
International Classification:
A01K 67/033, A01K 67/027, G01N 33/00, C12N 15/63, C12N 15/00
US Classification:
800 18, 800 3, 800 13, 800 14, 4353201, 435455
Abstract:
The present invention deals with gene therapy for treating chronic heart failure and other cardiac disease states which are accompanied by a reduced number or functioning of myocardial beta-adrenergic receptors (β-AR). β-AR receptor function is augmented in transgenic animals by delivery and expression of a beta-2-adrenergic receptor gene or a gene encoding a beta adrenergic receptor kinase inhibitor, resulting in increased in vivo left ventricular function. The present invention includes recombinant plasmid vectors, alternative beta-adrenergic receptor gene delivery strategies, and transgenic mice carrying a β-AR transgene, a β-ARK transgene, or a β-ARK inhibitor transgene.